Mark Tyndall

Insider Reports History

Location
Washington, DC
Signature
/s/ Mark Tyndall
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Tyndall:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keenova Therapeutics plc EVP & CLO and Corp Sec Ordinary Shares 8,167 $724,821 $88.75 01 Jan 2026 Direct
Keenova Therapeutics plc EVP & CLO and Corp Sec Restricted Stock Units 46,031 01 Jan 2026 Direct

Insider Reports Filed by Mark Tyndall

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465926000784-tyndall-mark-anthony-2026-01-01 Keenova Therapeutics plc 01 Jan 2026 3 $0 4 EVP & CLO and Corp Sec 05 Jan 2026, 18:04
Mallinckrodt plc 31 Jul 2025 1 $0 4 EVP & CLO and Corp Sec 04 Aug 2025, 20:50
NONE Mallinckrodt plc 01 Jan 2025 3 $0 4 EVP & CLO and Corp Sec 02 Jan 2025, 17:03
NONE Mallinckrodt plc 02 Feb 2024 1 $0 4 EVP & Chief Legal Offi & Secre 06 Feb 2024, 16:36
MNKTQ Mallinckrodt plc 14 Nov 2023 1 $0 4 EVP & Chief Legal Offi & Secre 16 Nov 2023, 16:10
MNK Mallinckrodt plc 17 Aug 2023 1 -$7,823 4 EVP & Chief Legal Offi & Secre 18 Aug 2023, 21:23
MNK Mallinckrodt plc 30 Jun 2023 1 $0 4 EVP & Chief Legal Offi & Secre 05 Jul 2023, 18:18
MNK Mallinckrodt plc 03 Apr 2023 1 $0 4 EVP & Chief Legal Offi & Secre 05 Apr 2023, 19:05
MNK Mallinckrodt plc 14 Dec 2022 1 $0 4 EVP & Chief Legal Offi & Secre 22 Dec 2022, 16:50
MNKPF Mallinckrodt plc 17 Aug 2022 0 $0 3 EVP & Chief Legal Offi & Secre 29 Aug 2022, 21:45